The Lancet

Eribulin versus S-1 as first or second-line chemotherapy to assess health-related quality ...

Copyright: © 2024 The Authors. Published by Elsevier Ltd. Three hundred and two patients were enrolled, with 152 and 148 assigned to the eribulin and S-1 groups ...